Drug intelligence / Profile preview

Farmalider

Development stage
Unknown
Lead developer
FARMALIDER
Modality
Small Molecules
Administration
Oral
01

Overview

Farmalider refers to a portfolio of analgesic and antipyretic medications developed by Farmalider S.A., a Spanish pharmaceutical company specializing in the development and licensing of generic and value-added drug products. The product line primarily includes formulations of ibuprofen and paracetamol (acetaminophen), which are indicated for the treatment of mild to moderate pain, fever, and inflammation. These active ingredients work by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins that mediate pain and inflammatory responses. Farmalider is known for its diverse range of dosage forms, including oral solutions, tablets, and sachets, many of which are licensed to other pharmaceutical companies for global distribution. The company was acquired by Aurobindo Pharma in 2014, which now oversees its manufacturing and commercialization efforts.

Brand names
FarmaliderIbudolDolostop
Other names
Ibuprofeno FarmaliderParacetamol Farmalider
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Farmalider.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Farmalider.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call